The findings indicated that the compounds demonstrated moderate antimicrobial efficacy against Gram-positive bacteria, whereas Gram-negative bacteria were often less susceptible.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Two functional compounds, methyl 2-benzoylbenzoate (MBB) and 4-Phenyl-1-(2H)-phthalazinone (PPZ), were prepared via optimized synthetic procedures.
📊
Key Findings & Data:The findings indicated that the compounds demonstrated moderate antimicrobial efficacy against Gram-positive bacteria, whereas Gram-negative bacteria were often less susceptible.
💡
Conclusion & Impact:The findings indicate that the examined compounds possess restricted yet selective antibacterial efficacy, especially against Gram-positive bacteria.
Two functional compounds, methyl 2-benzoylbenzoate (MBB) and 4-Phenyl-1-(2H)-phthalazinone (PPZ), were prepared via optimized synthetic procedures. The molecular structures of the synthesized compounds were elucidated using ¹H and ¹³C NMR spectroscopy, FT-IR spectroscopy, and elemental analysis. The antimicrobial efficacy of the target compounds (MBB and PPZ) was assessed utilizing the minimum inhibitory concentration (MIC) method. The findings indicated that the compounds demonstrated moderate antimicrobial efficacy against Gram-positive bacteria, whereas Gram-negative bacteria were often less susceptible. No antifungal efficacy was detected against the examined Candida species. The findings indicate that the examined compounds possess restricted yet selective antibacterial efficacy, especially against Gram-positive bacteria.
Çakmak, Ş., Yıldırım, N., Veyisoğlu, A., Odabaşoğlu, H. Y., Odabaşoğlu, M. (2026). Chemical Synthesis, Structural Characterization and Antimicrobial Properties of Methyl 2-Benzoylbenzoate and 4-Phenyl-1-(2H)-phthalazinone Compounds. Sakarya University Journal of Science, Volume: 30 Issue: 3. https://doi.org/10.16984/saufenbilder.1894553
K. Mourad, A. Makhlouf, A. Y. Soliman, and S. Mohamed, “Phthalazines and phthalazine hybrids as antimicrobial agents: Synthesis and biological evaluation,” J. Chem. Res., vol. 44, pp. 31–41, 2020, doi: 10.1177/1747519819883840.
T. Biswas, R. K. Mittal, V. Sharma, Kanupriya, and I. Mishra, “Nitrogen-fused heterocycles: Empowering anticancer drug discovery,” Med. Chem., vol. 20, no. 4, pp. 369–384, 2024, doi: 10.2174/0115734064278334231211054053.
H. Moustafa, H. A. El-Sayed, R. A. A. El-Hady, A. Z. Haikal, and M. El-Hashash, “Synthesis, antiviral, and antimicrobial activity of N- and S-alkylated phthalazine derivatives,” J. Heterocycl. Chem., vol. 53, pp. 789–799, 2015, doi: 10.1002/jhet.2316.
W. Ettahiri, R. Salim, M. Adardour, E. Ech-chihbi, I. Yunusa, M. M. Alanazi, S. Lahmidi, A. E. Barnossi, O. Merzouki, A. Iraqi Housseini, Z. Rais, A. Baouid, and M. Taleb, “Synthesis, characterization, antibacterial, antifungal and anticorrosion activities of 1,2,4-triazolo[1,5-a]quinazolinone,” Molecules, vol. 28, no. 14, Art. no. 5340, 2023, doi: 10.3390/molecules28145340.
K. Kushawaha, A. K. Jaiswal, P. Kumar, S. Katiyar, R. Baghel, H. Bhatt, J. Gupta, A. Ansari, P. Yadav, I. Ahmad, A. D. Choudhury, R. S. Bhatta, A. K. Tamrakar, and K. V. Sashidhara, “Development of novel phthalazinone-triazole hybrids as potential antidiabetic agents targeting GLUT4 translocation in skeletal muscle,” J. Med. Chem., vol. 68, no. 11, pp. 10722–10737, 2025, doi: 10.1021/acs.jmedchem.4c02615.
M. Asif, “Pharmacological activities of various phthalazine and phthalazinone derivatives,” Chem. Int., vol. 5, no. 1, pp. 97–108, 2019, doi: 10.31221/osf.io/2ga84.
M. S. Behalo, I. A. Gad El-Karim, and R. Rafaat, “Synthesis of novel phthalazine derivatives as potential anticancer and antioxidant agents based on 1-chloro-4-(4-phenoxyphenyl) phthalazine,” J. Heterocycl. Chem., vol. 54, no. 6, pp. 3591–3599, 2017, doi: 10.1002/jhet.2985.
W. Ettahiri, D. Fadili, M. M. Alanazi, M. Adardour, M. Akhazane, A. Taleb, Z. Rais, L. Mansour, A. Baouid, and M. Taleb, “Anticancer effect of novel phthalazines derivatives: Synthesis, biological evaluation, DFT, ADMET and docking study,” J. Mol. Struct., vol. 1327, Art. no. 141173, 2025, doi: 10.1016/j.molstruc.2024.141173.
M. M. Khalaf, H. M. Abd El-Lateef, M. Gouda, A. A. Abdelhamid, A. A. Amer, A. Alfarsi, M. N. Almarri, and A. Abdou, “New phthalazine based nickel(II), cobalt(II), and copper(II) mixed-ligand complexes; characterization, physicochemical properties, anti-inflammatory, antifungal, antibacterial, DFT and molecular docking exploration,” J. Indian Chem. Soc., vol. 101, no. 8, Art. no. 101191, 2024, doi: 10.1016/j.jics.2024.101191.
H. El-Wahab, H. M. Mohamed, A. M. El-Agrody, M. A. El-Nassag, and A. H. Bedair, “Synthesis and biological screening of 4-benzyl-2H-phthalazine derivatives,” Pharmaceuticals, vol. 4, pp. 1158–1170, 2011, doi: 10.3390/ph4081158.
H. M. R. de Souza, J. S. Guedes, R. H. C. N. Freitas, L. G. V. Gelves, H. H. Fokoue, C. M. R. Sant’Anna, E. J. Barreiro, and L. M. Lima, “Comparative chemical and biological hydrolytic stability of homologous esters and isosteres,” J. Enzyme Inhib. Med. Chem., vol. 37, no. 1, pp. 718–727, 2022, doi: 10.1080/14756366.2022.2027933.
G. Zhou, “Exploring ester prodrugs: A comprehensive review of approaches, applications, and methods,” Pharmacol. Pharm., vol. 15, pp. 269–284, 2024, doi: 10.4236/pp.2024.158016.
R. Karaman, “Prodrugs design based on inter- and intramolecular chemical processes,” Chem. Biol. Drug Des., vol. 82, pp. 643–668, 2013, doi: 10.1111/cbdd.12224.
S. Ortega-Requena, C. Montiel, F. Máximo, M. Gómez, M. D. Murcia, and J. Bastida, “Esters in the food and cosmetic industries: An overview of the reactors used in their biocatalytic synthesis,” Materials, vol. 17, no. 1, Art. no. 268, 2024, doi: 10.3390/ma17010268.
J. Xiong, H.-F. Zhu, Y.-J. Zhao, Y.-J. Lan, J.-W. Jiang, J.-J. Yang, and S.-F. Zhang, “Synthesis and antitumor activity of amino acid ester derivatives containing 5-fluorouracil,” Molecules, vol. 14, no. 9, pp. 3142–3152, 2009, doi: 10.3390/molecules14093142.
Raza, M. A. Khan, I. Ahmad, A. Bari, A. Masood, F. Ullah, and B. Awan, “Aceclofenac derivatives: Synthesis, characterization, and determination of antioxidant and anti-inflammatory activities by chemiluminescence assays and molecular docking studies,” ChemistrySelect, vol. 8, Art. no. e202300249, 2023, doi: 10.1002/slct.202300249.
J. d. M. S. Oliveira, D. d. N. Alves, M. C. Duarte, R. D. d. Castro, Y. Perez-Castillo, and D. P. de Sousa, “Salicylic acid derivatives as antifungal agents: Synthesis, in vitro evaluation, and molecular modeling,” Chemistry, vol. 7, no. 5, Art. no. 151, 2025, doi: 10.3390/chemistry7050151.
E. Feldeková, M. Kosová, M. Berčíková, M. Dragoun, I. Klojdová, I. Hrádková, and J. Šmidrkal, “Antimicrobial properties of phenolic acid alkyl esters,” Czech J. Food Sci., vol. 40, no. 6, pp. 438–446, 2022, doi: 10.17221/135/2022-CJFS.
M. Siddique, A. B. Saeed, N. A. Dogar, and S. Ahmad, “Biological potential of synthetic hydrazide based Schiff bases,” Int. J. Innov. Sci. Res., vol. 2, no. 3, pp. 651–657, 2013.
M. Jankulovska, K. Colanceska-Ragenovik, V. Dimova, I. Spirevska, and P. Makreski, “Synthesis and characterization of new p-substituted aromatic hydrazones,” Org. Chem. Indian J., vol. 8, no. 9, pp. 326–334, 2012.
R. Schwalbe, L. Steele-Moore, and A. C. Goodwin, Eds., Antimicrobial Susceptibility Testing Protocols, 1st ed. Boca Raton, FL, USA: CRC Press, 2007.
R. N. Lewis, R. N. McElhaney, W. Pohle, and H. H. Mantsch, “Components of the carbonyl stretching band in the infrared spectra of hydrated 1,2-diacylglycerolipid bilayers: A reevaluation,” Biophys. J., vol. 67, no. 6, pp. 2367–2375, 1994.
M. Mashima, “Infrared absorption spectra of hydrazides. II. Sodium hydrazides,” Bull. Chem. Soc. Jpn., vol. 35, no. 2, pp. 338–344, 1962.
D. H. Williams and I. Fleming, Spectroscopic Methods in Organic Chemistry. New York, NY, USA: McGraw-Hill, 1996.
S. M. Emam, S. M. E. Rayes, I. A. I. Ali, H. A. Soliman, and M. S. Nafie, “Synthesis of phthalazine-based derivatives as selective anti-breast cancer agents through EGFR-mediated apoptosis: In vitro and in silico studies,” BMC Chem., vol. 17, no. 1, Art. no. 90, 2023, doi: 10.1186/s13065-023-00995-2.
R. M. Butnariu, M. D. Caproșu, V. Bejan, I. I. Mangalagiu, M. Ungureanu, A. Poiată, C. Tuchiluș, and M. Florescu, “Pyridazine and phthalazine derivatives with potential antimicrobial activity,” J. Heterocycl. Chem., vol. 44, no. 5, pp. 1149–1152, 2007, doi: 10.1002/jhet.5570440528.